Provention Bio onboards Rita Jain, M.D., to Board of Directors
Provention Bio, Inc. (the “Company”), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, recently announced the appointment of Rita Jain, M.D., to the Company’s Board of Directors. Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, Inc., AbbVie, Abbott Laboratories, and […]
